4.5 Article

Copper pathology in vulnerable brain regions in Parkinson's disease

Journal

NEUROBIOLOGY OF AGING
Volume 35, Issue 4, Pages 858-866

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2013.09.034

Keywords

Copper; Copper transporter 1 (Ctr1); Human brain; Parkinson's disease; Substantia nigra; Superoxide dismutase 1 (SOD1)

Funding

  1. National Health and Medical Research Council of Australia
  2. Schizophrenia Research Institute
  3. National Institute of Alcohol Abuse and Alcoholism (National Institutes of Health) [R24AA012725]
  4. Sydney Brain Bank
  5. Neuroscience Research Australia
  6. University of New South Wales
  7. Partenariats Hubert Curien (PHC)-FAST
  8. Australian Department of Innovation, Industry, Science and Research International Science Linkage FAST programs
  9. Parkinson's New South Wales
  10. Parkinson's Australia Capital Territory
  11. 36th District of Quota International
  12. AMP
  13. Australian Postgraduate Award

Ask authors/readers for more resources

Synchrotron-based x-ray fluorescence microscopy, immunofluorescence, and Western blotting were used to investigate changes in copper (Cu) and Cu-associated pathways in the vulnerable substantia nigra (SN) and locus coeruleus (LC) and in nondegenerating brain regions in cases of Parkinson's disease (PD) and appropriate healthy and disease controls. In PD and incidental Lewy body disease, levels of Cu and Cu transporter protein 1, were significantly reduced in surviving neurons in the SN and LC. Specific activity of the cuproprotein superoxide dismutase 1 was unchanged in the SN in PD but was enhanced in the parkinsonian anterior cingulate cortex, a region with a-synuclein pathology, normal Cu, and limited cell loss. These data suggest that regions affected by a-synuclein pathology may display enhanced vulnerability and cell loss if Cu-dependent protective mechanisms are compromised. Additional investigation of copper pathology in PD may identify novel targets for the development of protective therapies for this disorder. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available